Akari Therapeutics Plc ROIC
What is the ROIC of Akari Therapeutics Plc?
The ROIC of Akari Therapeutics Plc is -131.14%
What is the definition of ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC of companies in the Health Care sector on NASDAQ compared to Akari Therapeutics Plc
What does Akari Therapeutics Plc do?
akari is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat orphan autoimmune and inflammatory diseases. akari’s lead drug, coversin, a second-generation and potentially best-in-class complement inhibitor, acts on complement component-c5, preventing release of c5a and formation of c5b – 9 (also known as the membrane attack complex or mac). coversin is a recombinant small protein (16,740 da) derived from a native protein discovered in the saliva of the ornithodoros moubata tick, where it modulates the host immune system to allow the parasite to feed without alerting the host to its presence or provoking an immune response.
Companies with roic similar to Akari Therapeutics Plc
- Hardy Oil and Gas plc has ROIC of -132.69%
- Corvus Gold has ROIC of -132.33%
- CO2 Gro has ROIC of -132.12%
- Meat-Tech 3D Ltd has ROIC of -131.89%
- Gratomic has ROIC of -131.71%
- Alternate Health has ROIC of -131.22%
- Akari Therapeutics Plc has ROIC of -131.14%
- Ideanomics Inc has ROIC of -130.90%
- Claren has ROIC of -130.90%
- KWESST Micro Systems has ROIC of -130.86%
- KWESST Micro Systems has ROIC of -130.86%
- Hancock Jaffe Laboratories Inc has ROIC of -130.76%
- Tetra Bio-Pharma has ROIC of -130.74%